• Mashup Score: 0

    Ruchika Talwar and Ian Berger discuss a Urology Practice publication on inpatient hematuria evaluation costs in rural for-profit hospitals. Berger reveals that rural for-profit hospitals’ costs are significantly higher than their non-profit counterparts, with a price increase of up to 80% for intermediate-risk and about 60% for high-risk evaluations. He attributes this disparity to the lack of…

    Tweet Tweets with this article
    • Unveiling price disparities: Exploring inpatient #hematuria evaluation costs in rural for-profit hospitals. Transparency and research are key to reducing #FinancialToxicity @ianberger217 @DukeUrology and @RuchikaTalwarMD @VUMCurology discuss on UroToday > https://t.co/Q2QQEc5s51 https://t.co/0FT5EE6x9L

  • Mashup Score: 1

    Ruchika Talwar and Ian Berger discuss a Urology Practice publication on inpatient hematuria evaluation costs in rural for-profit hospitals. Berger reveals that rural for-profit hospitals’ costs are significantly higher than their non-profit counterparts, with a price increase of up to 80% for intermediate-risk and about 60% for high-risk evaluations. He attributes this disparity to the lack of…

    Tweet Tweets with this article
    • Unveiling price disparities: Exploring inpatient #hematuria evaluation costs in rural for-profit hospitals. Transparency and research are key to reducing #FinancialToxicity @ianberger217 @DukeUrology and @RuchikaTalwarMD @VUMCurology discuss on UroToday > https://t.co/Q2QQEc5ZUz https://t.co/80aaxdqdIb

  • Mashup Score: 2

    Ruchika Talwar and Ian Berger discuss a Urology Practice publication on inpatient hematuria evaluation costs in rural for-profit hospitals. Berger reveals that rural for-profit hospitals’ costs are significantly higher than their non-profit counterparts, with a price increase of up to 80% for intermediate-risk and about 60% for high-risk evaluations. He attributes this disparity to the lack of…

    Tweet Tweets with this article
    • Unveiling price disparities: Exploring inpatient #hematuria evaluation costs in rural for-profit hospitals. Transparency and research are key to reducing #FinancialToxicity @ianberger217 @DukeUrology and @RuchikaTalwarMD @VUMCurology discuss on UroToday > https://t.co/Q2QQEc5s51 https://t.co/EKNXlUiO0E

  • Mashup Score: 0

    Yair Lotan joins Ashish Kamat in a slide presentation discussion on urine markers for hematuria and bladder cancer. Dr. Lotan overviews a number of recently published papers and new studies in this space. He highlights limitations and challenges with cytology, the current role of markers and where they stand in clinical use, and urinary markers that are available as well as in development for…

    Tweet Tweets with this article
    • Update on urine markers for #hematuria and #BladderCancer. @ylotan @UTSWUrology joins @UroDocAsh @MDAndersonNews in a presentation overviewing a number of recently published papers and new studies in this space. #WatchNow on UroToday > https://t.co/kX35Xvt0zY https://t.co/WiAJB5gDar